Cytosorbents Corp
CTSO
31 hedge funds and large institutions have $15.4M invested in Cytosorbents Corp in 2017 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 7 closing their positions.
181% more capital inflows, than outflows
Capital inflows: $4.54M | Capital outflows: $1.62M
60% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 5
1.93% more ownership
Funds ownership: 6.9% → 8.82% (+1.9%)
0% more funds holding
Funds holding: 31 → 31 (0)
0% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 7
18% less call options, than puts
Call options by funds: $406K | Put options by funds: $496K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.77M |
| 2 |
MHP
Manatuck Hill Partners
Westport,
Connecticut
|
+$764K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$536K |
| 4 |
WAP
Wealthcare Advisory Partners
West Chester,
Pennsylvania
|
+$300K |
| 5 |
Virtu Financial
New York
|
+$277K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$740K |
| 2 |
Skylands Capital
Milwaukee,
Wisconsin
|
-$480K |
| 3 |
Advisor Group
Phoenix,
Arizona
|
-$192K |
| 4 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$91.7K |
| 5 |
Private Advisor Group
Morristown,
New Jersey
|
-$43K |
CTSO Hedge Fund Activity: Q3 2017 in Review
31 of the 4,023 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q3 2017, worth a combined $15.4M — up 85% from $8.34M a quarter earlier.
Fund positioning in CTSO was balanced in Q3 2017: 7 funds opened new positions, 7 closed out, 8 added to existing stakes and 5 trimmed.
The largest buyer was Vanguard Group, adding an estimated $1.77M. The largest seller was Sabby Management, exiting entirely with an estimated $740K sold.
- 31 institutional investors held Cytosorbents Corp (CTSO) as of Q3 2017, unchanged from Q2 2017.
- Funds reported $15.4M of Cytosorbents Corp stock for Q3 2017, up 85% quarter-over-quarter.
- 7 funds opened new Cytosorbents Corp positions in Q3 2017 and 7 closed out, a net change of 0 holders.
- The largest Cytosorbents Corp buyer in Q3 2017 was Vanguard Group, an estimated $1.77M added.
- The largest Cytosorbents Corp seller in Q3 2017 was Sabby Management, an estimated $740K sold.
Based on aggregated 13F filings for Q3 2017.